# MBX Biosciences, Inc.: Form SC 13D, filed Sep 23, 2024

- Company: [MBX Biosciences, Inc.](/companies/mbx.md) (CIK 1776111)
- Form: SC 13D
- Filed: 2024-09-23
- Accepted by EDGAR: Sep 23, 2024, 18:07 ET
- Period: not reported
- Accession: 0001104659-24-102144
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1776111/000110465924102144/tm2424545d1_sc13d.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1776111/000110465924102144/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1776111/000110465924102144/tm2424545d1_sc13d.htm

Filed Sep 23, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-102144. Last ingested by Listed: Nov 12, 2026, 18:07 ET. No prices; not investment advice.
